Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study

AIM: Most patients with Alzheimer's disease (AD) experience poor food intake and/or loss of appetite, which accelerates cognitive impairment. Several reports have shown that rivastigmine improves appetite in AD patients. The present study investigated the efficacy of a rivastigmine transdermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuno, Norifumi, Mori, Takahiro, Ishikawa, Ichiro, Bando, Nobuyasu, Park, Haeyoung, Matsumoto, Yoshito, Mori, Itsuko, Tanaka, Mariko, Hirano, Takayuki, Nakamura, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles: Epidemiology, Clinical Practice and Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850597/
https://www.ncbi.nlm.nih.gov/pubmed/30864298
http://dx.doi.org/10.1111/ggi.13644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850597/
https://www.ncbi.nlm.nih.gov/pubmed/30864298
http://dx.doi.org/10.1111/ggi.13644

Ejemplares similares